The National Testing Agency (NTA) is set to close the application correction window for the Common University Entrance Test-Postgraduate (CUET PG) 2026 today, January 30.
AMPLITUDE is the first clinical trial to evaluate potential therapies for patients with mHSPC and known HRR gene alterations, with positive results supporting the niraparib-based combination regimen a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results